Rhaeos
Dr. Alex Burton started his biomedical engineering career 8 years ago developing algorithms to extract physiological responses collected with body-worn devices to determine behavioral and environmental impacts on the well-being of patients and office workers. Since then, he has transitioned into implementing medical device designs to interface with the central and peripheral nervous systems. He has >10 published works including peer-reviewed papers and review articles on fully implantable wireless, battery-free, electronics, and a patent on non-invasive techniques to map current density patterns from deep brain stimulators. He earned both his BS and Ph.D. in Biomedical Engineering from the University of Arizona specializing in mechanics and medical device sensors.
Rhaeos
1 followers
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.